Mark Cuban-Backed Startup Uses AI to Fight Denied Health Claims

Since he was 12, Bryan Kopsick has gotten an infusion of a drug called Remicade every eight weeks to control his Crohn’s disease, a painful bowel inflammation that can cause severe diarrhea. The medication lets Kopsick, now 30, caddy professionally on the PGA Tour and at other golf tournaments. This Jan. 1, however, his health insurance changed, and the new company, UnitedHealthcare, wanted him to try cheaper alternatives to Remicade, which costs tens of thousands of dollars a year. “My heart started beating fast,” Kopsick says. He didn’t want to mess with a treatment that had worked for more ...